Updated Nov. 16, 2012 at 7:29 a.m.

Premium Lock Drug failure triggers 76% crushing of Tranzyme stock

Published: 2012-11-15 11:52:00
Updated: 2012-11-16 07:29:49


Shares in Tranzyme Pharma plummeted 76 percent Thursday after the RTP-based company announced failure of a drug that it hoped would treat diabetics suffering from gastroparesis....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders